title: Susceptibility to HSV-1 infection and exercise stress in female mice: role of estrogen.
abstract: Exhaustive exercise has been associated with an increased risk for upper respiratory tract infections in mice and humans. We have previously shown (Brown AS, Davis JM, Murphy AE, Carmichael MD, Ghaffer A, Mayer EP. Med Sci Sports Exerc 36: 1290-1295, 2004) that female mice are better protected from the lethal effects of herpes simplex virus type 1 (HSV-1) infection, both at rest and following exercise stress, but little is known about possible mechanisms. This study tested the effects of estrogen on HSV-1 infection and macrophage antiviral resistance following repeated exhaustive exercise. Female mice were assigned to either exercise (Ex) or control (C): intact female (I-C or I-Ex), ovariectomized female (O-C or O-Ex), or ovariectomized estrogen-supplemented female (E-C or E-Ex). Exercise consisted of treadmill running to volitional fatigue ( approximately 125 min) for 3 consecutive days. Intact female mice had a later time to death than O and E (P < 0.05) and fewer deaths than both O and E (P < 0.05). Exercise stress was associated with increased time to sickness (P < 0.05) and symptom severity at days 6 and 12-21 postinfection (P < 0.05) and decreased macrophage antiviral resistance (P < 0.001) in all groups. E had increased symptom severity at days 6 and 13-21 postinfection (P < 0.05). Results indicate that intact female mice are better protected from the lethal effects of HSV-1 infection and that exercise stress had a similar negative impact in all groups. This protective effect was lost in ovariectomized mice, but it was not reinstated by 17beta-estradiol replacement. This indicates that other ovarian factors, alone or in combination with estrogen, are responsible for the protective effects in females.
authors.affiliation: Division of Applied Physiology, Arnold School of Public Health, University of South Carolina, SC 29208, USA.
authors.forename: A S
authors.initials: AS
authors.lastname: Brown
authors.forename: J M
authors.initials: JM
authors.lastname: Davis
authors.forename: E A
authors.initials: EA
authors.lastname: Murphy
authors.forename: M D
authors.initials: MD
authors.lastname: Carmichael
authors.forename: J A
authors.initials: JA
authors.lastname: Carson
authors.forename: A
authors.initials: A
authors.lastname: Ghaffar
authors.forename: E P
authors.initials: EP
authors.lastname: Mayer
mesh_terms: D000818:Animals; D001835:Body Weight; D002470:Cell Survival; D002478:Cells, Cultured; D004195:Disease Models, Animal; D004343:Drug Implants; D004958:Estradiol / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D005260:Female; D006561:Herpes Simplex / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D018259:Herpesvirus 1, Human / Q000472:pathogenicity*; D017737:Macrophages, Peritoneal / Q000378:metabolism / Q000821:virology; D051379:Mice; D009929:Organ Size; D010052:Ovariectomy; D005082:Physical Exertion; D012720:Severity of Illness Index; D013312:Stress, Physiological / Q000150:complications* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D013997:Time Factors; D014599:Uterus / Q000378:metabolism / Q000473:pathology